[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:primary-amyloidosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":129,"states":130},"Primary Amyloidosis",19,14,[8,16,22,28,35,42,48,55,61,67,73,79,85,91,97,104,111,117,123],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07081646","A Phase 1b\u002F2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:30.699880Z","2026-07-05T05:32:16.731350Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07075510","Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders",[12],"2026-08-26T02:17:19.710918Z","2026-05-05T02:43:29.371668Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05145816","Phase 1\u002F2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis",[12],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:29.154065Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT06022939","Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis",[32],"Phase 3","2026-08-26T02:19:23.493898Z","2026-05-05T02:43:28.714146Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT07110844","Teclistamab-Daratumumab in AL Amyloidosis",[39],"Phase 2","2026-08-26T02:18:22.309547Z","2026-05-05T02:43:28.362441Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06158854","A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion",[12],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:28.285425Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT05652335","A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis",[52],"Phase 1","2026-08-26T02:17:15.156099Z","2026-05-05T02:43:27.799689Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT05898646","Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial",[39],"2026-08-26T02:18:25.327036Z","2026-05-05T02:43:27.601694Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06292780","A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)",[12],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:27.478960Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06569147","Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis",[12],"2026-08-26T02:18:17.950264Z","2026-05-05T02:43:27.288200Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT02641145","Molecular Imaging of Primary Amyloid Cardiomyopathy",[],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:27.182067Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT01408225","Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource",[],"2026-08-26T02:15:00.557154Z","2026-05-13T02:55:06.071689Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT05598879","Global Cardio Oncology Registry",[],"2026-08-26T02:19:08.084946Z","2026-05-13T02:55:06.364374Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT03616483","The Indiana Myeloma Registry",[],"2026-08-26T02:16:39.977107Z","2026-05-13T02:55:06.173594Z",{"nct_id":98,"title":99,"phases":100,"status":101,"updated_at":102,"content_modified":103},"NCT07524634","Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis",[39],"NOT_YET_RECRUITING","2026-08-26T02:15:43.339060Z","2026-05-05T02:43:28.517574Z",{"nct_id":105,"title":106,"phases":107,"status":108,"updated_at":109,"content_modified":110},"NCT04847453","Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis",[52],"ACTIVE_NOT_RECRUITING","2026-08-03T02:38:34.966507Z","2026-05-05T02:43:29.693654Z",{"nct_id":112,"title":113,"phases":114,"status":108,"updated_at":115,"content_modified":116},"NCT05951049","A Study of AT-02 in Subjects With Systemic Amyloidosis.",[39],"2026-08-03T02:32:57.702658Z","2026-05-05T02:43:29.133602Z",{"nct_id":118,"title":119,"phases":120,"status":108,"updated_at":121,"content_modified":122},"NCT05451771","Venetoclax-Dexamethasone in Relapsed and\u002For Refractory t(11;14) Amyloidosis",[12],"2026-08-03T03:31:44.965184Z","2026-05-05T02:43:27.816636Z",{"nct_id":124,"title":125,"phases":126,"status":108,"updated_at":127,"content_modified":128},"NCT06097832","Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis",[12],"2026-08-03T02:09:46.172607Z","2026-05-05T02:35:31.911593Z",[],[131,135,139,142,146,150,153,157,161,164,167,170,173,176,180,183,186,189,192],{"state":132,"count":133,"slug":134},"Massachusetts",10,"massachusetts",{"state":136,"count":137,"slug":138},"New York",9,"new-york",{"state":140,"count":137,"slug":141},"Ohio","ohio",{"state":143,"count":144,"slug":145},"Minnesota",7,"minnesota",{"state":147,"count":148,"slug":149},"California",6,"california",{"state":151,"count":148,"slug":152},"Tennessee","tennessee",{"state":154,"count":155,"slug":156},"Texas",5,"texas",{"state":158,"count":159,"slug":160},"Florida",4,"florida",{"state":162,"count":159,"slug":163},"Michigan","michigan",{"state":165,"count":159,"slug":166},"Missouri","missouri",{"state":168,"count":159,"slug":169},"North Carolina","north-carolina",{"state":171,"count":159,"slug":172},"Pennsylvania","pennsylvania",{"state":174,"count":159,"slug":175},"Wisconsin","wisconsin",{"state":177,"count":178,"slug":179},"Arizona",3,"arizona",{"state":181,"count":178,"slug":182},"Georgia","georgia",{"state":184,"count":178,"slug":185},"Kansas","kansas",{"state":187,"count":178,"slug":188},"Maryland","maryland",{"state":190,"count":178,"slug":191},"Oregon","oregon",{"state":193,"count":178,"slug":194},"Utah","utah"]